Literature DB >> 9563556

Recent advances in the treatment of patients with malignant melanoma.

R A Evans.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9563556      PMCID： PMC1191326          DOI： 10.1097/00000658-199804000-00031

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  Malignant melanoma: primary surgical management (excision and node dissection) based upon pathology and staging.

Authors:  R A Evans
Journal:  Cancer       Date:  1995-12-01       Impact factor: 6.860

2.  Natural killer cells and the Guy's Hospital trials.

Authors:  R A Evans
Journal:  Arch Surg       Date:  1988-07

Review 3.  Recent advances in the care of the patient with malignant melanoma.

Authors:  D Reintgen; C M Balch; J Kirkwood; M Ross
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

4.  Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

Authors:  C M Balch; S J Soong; A A Bartolucci; M M Urist; C P Karakousis; T J Smith; W J Temple; M I Ross; W R Jewell; M C Mihm; R L Barnhill; H J Wanebo
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

5.  Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.

Authors:  C L Slingluff; K R Stidham; W M Ricci; W E Stanley; H F Seigler
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

6.  Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities.

Authors:  U Veronesi; J Adamus; D C Bandiera; O Brennhovd; E Caceres; N Cascinelli; F Claudio; R L Ikonopisov; V V Javorski; S Kirov; A Kulakowski; J Lacour; F Lejeune; Z Mechl; A Morabito; I Rodé; S Sergeev; E van Slooten; K Szczygiel; N N Trapeznikov; R I Wagner
Journal:  Cancer       Date:  1982-06-01       Impact factor: 6.860

7.  Host resistance to carcinoma of the breast.

Authors:  R A Evans
Journal:  South Med J       Date:  1980-09       Impact factor: 0.954
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.